Novel immunotherapy approaches have revolutionised the treatment of certain cancers in recent years. Since the first results from checkpoint inhibitor therapy were published, we have gained further understanding of the underlying mechanisms and the potential of immunotherapy. Anne Gromöller, PhD at INC Research, provides an overview of this exciting and rapidly expanding field.
Watch 2 – Advances in ASCO